亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Clonal-pattern Seborrheic Keratosis

异型性 脂溢性角化病 医学 角化病 核异型性 皮肤病科 病理 免疫组织化学
作者
Joshua F. Goldsmith,Laleh Montaser Kouhsari,Steven R. Tahan
出处
期刊:The American Journal of Surgical Pathology [Ovid Technologies (Wolters Kluwer)]
卷期号:46 (12): 1642-1649 被引量:2
标识
DOI:10.1097/pas.0000000000001973
摘要

Seborrheic keratosis is a benign epidermal tumor. Seborrheic keratosis with clonal pattern (CPSK) displays histologic features distinct from other subtypes of SK (non-CPSK). We sought to quantitatively assess the risk of recurrence and progression to squamous cell carcinoma (SCC), either in situ or invasive, of incompletely excised CPSKs. We studied all 244 cases from 238 patients of “seborrheic keratosis, clonal pattern” diagnosed in our institution over a 10-year period (2008-2018). Demographic, clinical, pathologic, and follow-up data were gleaned from electronic health records. Following glass slide review, CPSK lesions were divided into 2 groups: CPSK with cytologic atypia and CPSK without cytologic atypia. For comparison, 107 non-CPSKs were studied as controls. The minimum follow-up period was 2 years (median=4 y). All lesions were incompletely excised. Eighteen of 244 CPSKs (7.4%) recurred at or adjacent to the site of initial partial removal compared with 1.9% of non-CPSKs. Five of the 18 (28%) recurrent CPSKs recurred as CPSK, 11 (61%) as SCC in situ, and 3 (17%) as invasive SCC. The mean time to recurrence was 3.1 years. Two non-CPSKs recurred as non-CPSKs. Overall CPSKs were more likely to recur than non-CPSKs ( P =0.04). CPSKs with atypia were more likely to recur than CPSKs without atypia ( P =0.03). The upgrade rate to SCC at least in situ of all recurrent CPSK lesions with atypia was 78%. Our results suggest that pathologists should report the presence of clonal pattern when observed in seborrheic keratoses, indicate the presence of atypia, and provide lesional margin assessment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
NexusExplorer应助ceeray23采纳,获得50
19秒前
和谐金毛完成签到,获得积分10
22秒前
23秒前
量子星尘发布了新的文献求助10
23秒前
虚心的砖家完成签到,获得积分10
25秒前
诚心幻莲发布了新的文献求助10
35秒前
52秒前
54秒前
56秒前
康康发布了新的文献求助10
1分钟前
李丽关注了科研通微信公众号
1分钟前
积极从蕾应助ceeray23采纳,获得20
1分钟前
完美世界应助ceeray23采纳,获得20
1分钟前
李爱国应助康康采纳,获得10
1分钟前
FashionBoy应助ceeray23采纳,获得20
1分钟前
李健应助ceeray23采纳,获得20
1分钟前
关关过应助ceeray23采纳,获得20
1分钟前
关关过应助ceeray23采纳,获得20
1分钟前
这学真难读下去完成签到,获得积分10
1分钟前
1分钟前
李丽发布了新的文献求助10
1分钟前
1分钟前
mickaqi完成签到 ,获得积分10
1分钟前
1分钟前
Ahan发布了新的文献求助10
1分钟前
秋雨梧桐叶落时完成签到,获得积分10
1分钟前
1分钟前
在水一方应助ceeray23采纳,获得20
2分钟前
巫马尔槐完成签到,获得积分10
2分钟前
Jayzie完成签到 ,获得积分10
2分钟前
2分钟前
iShine完成签到 ,获得积分10
2分钟前
闪闪的白梅完成签到,获得积分10
2分钟前
李爱国应助ceeray23采纳,获得20
2分钟前
2分钟前
咸鱼完成签到 ,获得积分10
2分钟前
爆米花应助科研通管家采纳,获得10
3分钟前
3分钟前
wanci应助ceeray23采纳,获得20
3分钟前
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Basic And Clinical Science Course 2025-2026 3000
人脑智能与人工智能 1000
花の香りの秘密―遺伝子情報から機能性まで 800
Silicon in Organic, Organometallic, and Polymer Chemistry 500
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
Pharmacology for Chemists: Drug Discovery in Context 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5606566
求助须知:如何正确求助?哪些是违规求助? 4691052
关于积分的说明 14866835
捐赠科研通 4707899
什么是DOI,文献DOI怎么找? 2542911
邀请新用户注册赠送积分活动 1508211
关于科研通互助平台的介绍 1472276